Skin Pigmentation Impacts the Clinical Diagnosis of Wound Infection: Imaging of Bacterial Burden to Overcome Diagnostic Limitations
Jonathan Johnson 1, Alton R Johnson Jr 2, Charles A Andersen 3, Martha R Kelso 4, Alisha R Oropallo 5, Thomas E Serena 6
1Comprehensive Wound Care Services and Capital Aesthetic & Laser Center, Washington, DC. 2University of Michigan School of Medicine in the Division of Metabolism, Endocrinology and Diabetes-Podiatry, Ann Arbor, MI. 3Madigan Army Medical Center Joint Base Lewis-McChord, Tacoma, WA. 4Wound Care Plus LLC, Blue Springs, MO. 5Comprehensive Wound Healing Center and Hyperbarics, Northwell Health and Department of Vascular Surgery, Zucker School of Medicine Hofstra/Northwell, Hempstead, NY. 6SerenaGroup Research Foundation, Cambridge, MA.
Journal of Racial and Ethnic Health Disparities (2023), April 2023
Related Publications
Detection of Bacterial Burden
Detection of Bacterial Burden
Detection of Bacterial Burden
Detection of Bacterial Burden
Detection of Bacterial Burden
Detection of Bacterial Burden
MolecuLight Headquarters
425 University Avenue Suite 700 Toronto, ON M5G 1T6 Canada
US Address MolecuLight Corp. 2403 Sidney Street, Suite 286 Pittsburgh, PA 15203
T. 1-877-818-4360
North American Toll Free:
1-877-818-4360
F.+1 647-362-4730
E: info@moleculight.com
©2024
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.